LP
PALI icon

LMR Partners’s Palisade Bio PALI Stock Holding History

LMR Partners’s Portfolio PALI Stock Details PALI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$26.9K Buy
+15,400
New +$28K ﹤0.01% 1334
2015
Q3 		– Hold
0
– -$174K – 439
2015
Q2 		– Hold
0
– – – 406
2014
Q2 		– Hold
0
– -$296K – 527
2014
Q1 		– Hold
0
– – – 190

Other funds holding PALI

Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
BGI
B Group Inc Dallas, Texas $135M AUM 80% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

LMR Partners's PALI Position: Q1 2026 in Review

LMR Partners opened a new position in Palisade Bio (PALI) in Q1 2026: 15,400 shares worth $26.9K. The stake represents ﹤0.01% of the portfolio and ranks #1334 among its holdings.

96 funds tracked by Wall St. Rank hold PALI as of Q1 2026.

  • LMR Partners held 15,400 shares of Palisade Bio worth $26.9K as of Q1 2026.
  • Palisade Bio was a new LMR Partners position in Q1 2026.
  • Palisade Bio made up ﹤0.01% of LMR Partners's portfolio in Q1 2026, its #1334 holding.
  • 96 funds tracked by Wall St. Rank held Palisade Bio as of Q1 2026.

Based on LMR Partners's 13F filing for Q1 2026, filed 15 May 2026.